Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.

Y Kawaguchi, K Suzuki, M Hara, T Hidaka… - Annals of the …, 1994 - ard.bmj.com
Y Kawaguchi, K Suzuki, M Hara, T Hidaka, T Ishizuka, M Kawagoe, H Nakamura
Annals of the rheumatic diseases, 1994ard.bmj.com
OBJECTIVES--To determine whether fibroblasts from patients with systemic sclerosis (SSc)
produce excessive amounts of endothelin-1 (ET-1), which is recognised as having
vasoconstrictive properties and as having a potent mitogenic effect on fibroblasts.
METHODS--Dermal fibroblasts were removed from 11 patients with SSc and from five
normal controls (NC). The assay of ET-1 protein was measured by an ELISA that used two
anti-ET-1 antibodies. The gene expression of prepro ET-1 mRNA was evaluated by a …
OBJECTIVES
To determine whether fibroblasts from patients with systemic sclerosis (SSc) produce excessive amounts of endothelin-1 (ET-1), which is recognised as having vasoconstrictive properties and as having a potent mitogenic effect on fibroblasts.
METHODS
Dermal fibroblasts were removed from 11 patients with SSc and from five normal controls (NC). The assay of ET-1 protein was measured by an ELISA that used two anti-ET-1 antibodies. The gene expression of prepro ET-1 mRNA was evaluated by a reverse-transcriptase polymerase chain reaction (RT-PCR) method.
RESULTS
Levels of ET-1 protein were significantly higher in SSc fibroblast cultures than in those of normal fibroblasts (p < 0.01). The expression of prepro ET-1 mRNA was also higher in SSc fibroblasts than in normal fibroblasts. The addition of interleukin-1 beta (IL-1 beta) increased the production of ET-1 by fibroblasts.
CONCLUSION
The findings indicate that the overproduction of ET-1 is a novel abnormal function in SSc fibroblasts, and that ET-1 induced by fibroblasts may play a role in the fibrosis and Raynaud's phenomenon of SSc.
ard.bmj.com